Partnering Opportunities
In-licensing
Novacta Therapeutics is currently seeking opportunities to in-license early anti infective programmes, ideally with activity against Gram-negative bacteria
Novacta Therapeutics would welcome contact from research institutions and biotech/biopharmaceutical companies that have targeted anti infective programmes, ranging from discovery stage to candidate selection stage. We are currently seeking the following development-stage drug candidates in the anti infective space:
- Gram-negative programme
-
Broad-spectrum anti-viral programme
Partnering
In addition to its in-licensing activities, Novacta Therapeutics is pursuing collaborative alliances based on its proprietary products and platform technology
Business development enquiries
To enquire about partnering opportunities with Novacta Therapeutics (in- or out-licensing) please contact:
Georg Buchner PhD MBA
VP of Corporate and Business Development
Tel: +44 (0) 1707356130
Fax: +44 (0) 1707356131
Mob: +44 (0) 7989596847
Email: georg.buchner@novactabio.com